Cargando…
Intrahepatic transcriptomics reveals gene signatures in chronic hepatitis B patients responded to interferon therapy
Chronic hepatitis B virus (HBV) infection remains a substantial public health burden worldwide. Alpha-interferon (IFNα) is one of the two currently approved therapies for chronic hepatitis B (CHB), to explore the mechanisms underlying IFNα treatment response, we investigated baseline and 24-week on-...
Autores principales: | Li, Ning, Yu, Kangkang, Dong, Minhui, Wang, Jinyu, Yang, Feifei, Zhu, Haoxiang, Yu, Jie, Yang, Jingshu, Xie, Wentao, Mitra, Bidisha, Mao, Richeng, Wu, Feizhen, Guo, Haitao, Zhang, Jiming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9336496/ https://www.ncbi.nlm.nih.gov/pubmed/35815389 http://dx.doi.org/10.1080/22221751.2022.2100831 |
Ejemplares similares
-
Human hepatocyte-enriched miRNA-192-3p promotes HBV replication through inhibiting Akt/mTOR signalling by targeting ZNF143 in hepatic cell lines
por: Li, Fahong, et al.
Publicado: (2022) -
Viral quasispecies quantitative analysis: a novel approach for appraising the immune tolerant phase of chronic hepatitis B virus infection
por: Wang, Mingjie, et al.
Publicado: (2021) -
The potential effect of HBV vaccination on off-treatment HBsAg reversion after interferon-induced HBsAg clearance
por: Jiang, Shaowen, et al.
Publicado: (2023) -
Hepatitis B virus promotes its own replication by enhancing RAB5A-mediated dual activation of endosomal and autophagic vesicle pathways
por: Zhao, Zhenyu, et al.
Publicado: (2023) -
Hepatitis B e antigen induces the expansion of monocytic myeloid-derived suppressor cells to dampen T-cell function in chronic hepatitis B virus infection
por: Yang, Feifei, et al.
Publicado: (2019)